New insight in immunotherapy and combine therapy in colorectal cancer

New insight in immunotherapy and combine therapy in colorectal cancer

The advent of immune checkpoint inhibitors (ICIs) in colorectal cancer (CRC) treatment marks a major breakthrough. These therapies have proven safer and more effective than traditional radiotherapy and targeted treatments. Immunotherapies like pembrolizumab, nivolumab, and ipilimumab have pioneered...

Full description

Saved in:
Bibliographic Details
Main Authors: Kai Ji, Hang Jia, Zixuan Liu, Guanyu Yu, Rongbo Wen, Tianshuai Zhang, Zhiying Peng, Wenjiang Man, Yucheng Tian, Can Wang, Qianlong Ling, Wei Zhang, Leqi Zhou, Mulin Liu, Bing Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
immunomodulatory
ICIS
radiotherapy
chemotherapy
combination therapy
colorectal cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2024.1453630/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2024.1453630/full

Similar Items